GRFT-R02 - Medical / Health Care
GRFT-R02 is a unique, highly osteogenic putty. This patented biomaterial is expected to allow surgeons to address difficult surgical situations like acetabular reconstruction, spinal postero-lateral fusion, non-union or complex cases of fracture healing with poor vascularization. GRFT-R02 shows osteoinductive properties to enhance bone regeneration and is able to repair a critical and segmental bone defects in animal models.
This biomaterial has demonstrated comparable efficacy to autograft in animal models and offers an alternative to expensive and higher risk bone morphogenetic proteins (BMPs).
GRFT-R02 is a combination of patented Bi-CaP Microparticules with whole blood. Once clotted, the material creates a fibrin mesh and acts like a hydrogel. The BiCaP technology includes controlled particle sizes (ranging from 80 to 200μm) and is composed of 60% Hydroxyhapatite and 40% βTCP. BiCaP Microparticules are enriched with Calcium ions, which facilitate blood clot formation.